Webinar

Leveraging past learnings for future-focused solutions to clinical manufacturing

The ThinkLive Cell and Gene Therapy Summit 2024 provided a forum for industry experts to explore leveraging past insights for future-focused solutions in clinical manufacturing. Moderated by Christian Schneider, Vice President and Head of Biopharma Excellence at PharmaLex, part of Cencora, the panel session featured accomplished professionals such as Dan O’Connor, Director, Regulatory and Early Access Policy at the Association of the British Pharmaceutical Industry (ABPI), Lisa Freeman, Vice President, Head of Regulatory Affairs at CRISPR Therapeutics, Christopher McMahon, Senior Director, Discovery, Research, at Fujifilm Cellular Dynamics, and Tamara T. Monesmith, Senior Vice President, Technical Development at Editas Medicine. 
webinar

The discussion touched upon aligning CMC development with clinical timelines, navigating EMA and FDA requirements, and optimizing regulatory strategies through joint scientific advice. Panelists discussed challenges like potency assurance, regulatory changes, and the role of bioinformatics in product characterization. They also explored the collaborative relationship between industry and regulators in shaping efficient pathways for novel therapies.  

Watch the full recording to learn more about early regulatory engagement, platform approaches, and health economics integration for successful drug development. 

 

Pardot Form
headshot

Adapting learnings to advance CGT clinical manufacturing

An expert panel came together at Cencora’s ThinkLive Gene Therapy Summit 2024 during a session titled, “Leveraging past learnings for future-focused solutions to clinical manufacturing.” Led by moderator Christian K. Schneider, M.D., Vice President and Head of BioPharma Excellence, Cencora PharmaLex, leaders from industry and former regulators discussed their experiences with Chemistry, Manufacturing, and Controls (CMC) and clinical manufacturing during early and late-stage development of cell and gene therapies.

Related resources

White paper

Mastering the complexities of targeted medicines
Learn more

Article

Addressing market access challenges as CGTs expand to larger patient populations
Learn more

Webinar

How to turn poor TMF quality into TMF operational excellence
Learn more

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.